Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
results entities : Evogene ltd. save search
Evogene Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-03-07 (Crawled : 12:00) - prnewswire.com
EVGN | $0.7 -13.64% 63K
|
Health Technology
|
| O: -3.08%
H: 10.0%
C: 6.66%
year financial results
Evogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024
Published: 2024-02-26 (Crawled : 16:00) - biospace.com/
EVGN | $0.7 -13.64% 63K
|
Health Technology
|
| O: -2.73%
H: 7.73%
C: 1.91%
conference financial results
Evogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024
Published: 2024-02-26 (Crawled : 12:00) - prnewswire.com
EVGN | $0.7 -13.64% 63K
|
Health Technology
|
| O: -2.73%
H: 7.73%
C: 1.91%
conference financial results
Evogene Reports Third Quarter 2023 Financial Results
Published: 2023-11-15 (Crawled : 15:30) - biospace.com/
EVGN | $0.7 -13.64% 63K
|
Health Technology
|
| O: 7.48%
H: 0.0%
C: -2.71%
financial results
Lavie Bio Reports Advancement in Bio-Fungicide Program Against Downy Mildew with 2023 Field Trial Results
Published: 2023-11-08 (Crawled : 12:00) - prnewswire.com
EVGN | $0.7 -13.64% 63K
|
Health Technology
|
| O: 3.45%
H: 1.07%
C: -2.76%
program trial results
Evogene Schedules Third Quarter 2023 Financial Results Release & Conference Call for November 15, 2023
Published: 2023-11-02 (Crawled : 11:00) - prnewswire.com
EVGN | $0.7 -13.64% 63K
|
Health Technology
|
| O: 0.0%
H: 11.98%
C: 6.97%
conference financial results
Evogene Reports Second Quarter 2023 Financial Results
Published: 2023-08-17 (Crawled : 12:00) - biospace.com/
EVGN | $0.7 -13.64% 63K
|
Health Technology
|
| O: -0.62%
H: 0.9%
C: -18.65%
financial results
Evogene Schedules Second Quarter 2023 Financial Results Release & Conference Call for August 17, 2023
Published: 2023-08-01 (Crawled : 15:00) - biospace.com/
EVGN | $0.7 -13.64% 63K
|
Health Technology
|
| O: -1.87%
H: 2.86%
C: 2.86%
conference financial results
Biomica Announces Interim Positive Results from Pre-Clinical Studies in its Irritable Bowel Syndrome (IBS) Program
Published: 2023-07-19 (Crawled : 13:00) - biospace.com/
EVGN | $0.7 -13.64% 63K
|
Health Technology
|
| O: 3.08%
H: 0.85%
C: -4.27%
pre-clinical positive program results
Evogene Reports First Quarter 2023 Financial Results
Published: 2023-05-18 (Crawled : 11:00) - prnewswire.com
EVGN | $0.7 -13.64% 63K
|
Health Technology
|
| O: -3.03%
H: 1.55%
C: -2.34%
financial results
Evogene Schedules First Quarter 2023 Financial Results Release & Conference Call for May 18, 2023
Published: 2023-05-04 (Crawled : 12:00) - biospace.com/
EVGN | $0.7 -13.64% 63K
|
Health Technology
|
| O: 1.75%
H: 3.45%
C: -1.72%
conference financial results
Evogene Reports Fourth Quarter and Full Year 2022 Financial Results
Published: 2023-03-09 (Crawled : 14:00) - biospace.com/
EVGN | $0.7 -13.64% 63K
|
Health Technology
|
| O: 1.39%
H: 4.25%
C: -5.47%
year financial results
Lavie Bio Reports Successful Results for its Bio-Fungicides Programs
Published: 2023-02-28 (Crawled : 12:20) - prnewswire.com
EVGN | $0.7 -13.64% 63K
|
Health Technology
|
| O: 2.72%
H: 0.0%
C: -1.31%
Evogene Schedules Fourth Quarter and Full Year 2022 Financial Results Release & Conference Call for March 9, 2023
Published: 2023-02-27 (Crawled : 14:00) - biospace.com/
EVGN | $0.7 -13.64% 63K
|
Health Technology
|
| O: -1.3%
H: 1.11%
C: -1.36%
conference year financial
Evogene Reports Third Quarter 2022 Financial Results
Published: 2022-11-17 (Crawled : 13:20) - biospace.com/
EVGN | $0.7 -13.64% 63K
|
Health Technology
|
| O: -5.84%
H: 7.25%
C: 7.25%
financial results
Evogene Financial Results and Earnings Announcement Schedule for the Second Quarter of 2022
Published: 2022-08-02 (Crawled : 18:00) - biospace.com/
EVGN | $0.7 -13.64% 63K
|
Health Technology
|
| O: 1.04%
H: 2.16%
C: 0.52%
announcement
Evogene Reports First Quarter 2022 Financial Results
Published: 2022-05-26 (Crawled : 12:00) - biospace.com/
EVGN | $0.7 -13.64% 63K
|
Health Technology
|
| O: -10.02%
H: 8.56%
C: 2.85%
results
Evogene Financial Results and Earnings Announcement Schedule for the Full Year and Fourth Quarter of 2021
Published: 2022-02-15 (Crawled : 13:00) - biospace.com/
EVGN | $0.7 -13.64% 63K
|
Health Technology
|
| O: 1.63%
H: 3.2%
C: 1.6%
financial results announcement results
Biomica Reports Positive Results from Pre-Clinical Studies in its Inflammatory Bowel Disease (IBD) Program
Published: 2021-11-30 (Crawled : 13:00) - biospace.com/
EVGN | $0.7 -13.64% 63K
|
Health Technology
|
| O: 2.72%
H: 0.0%
C: 0.0%
disease positive results pre-clinical positive results preclinical
Evogene Reports Third Quarter 2021 Financial Results
Published: 2021-11-17 (Crawled : 13:00) - biospace.com/
INVZ | News | $1.055 -1.4% -1.42% 2M
|
|
| O: 0.49%
H: 11.15%
C: 10.0%
NICE | $231.19 0.28% 0.28% 260K
|
Technology Services
|
| O: 0.13%
H: 0.0%
C: -1.85%
EVGN | $0.7 -13.64% 63K
|
Health Technology
|
| O: -1.67%
H: 6.81%
C: -2.13%
financial results results
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.